risankizumab

Summary

risankizumab is a type of chemical entity^[1]. risankizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (119 views/month).^[2]

Key Facts

• risankizumab's instance of is recorded as type of chemical entity^[3].
• risankizumab's CAS Registry Number is recorded as 1612838-76-2^[4].
• risankizumab's subclass of is recorded as chemical compound^[5].
• risankizumab's has use is recorded as medication^[6].
• risankizumab's Guide to Pharmacology Ligand ID is recorded as 8922^[7].
• risankizumab's UNII is recorded as 90ZX3Q3FR7^[8].
• risankizumab's DrugBank ID is recorded as DB14762^[9].
• risankizumab's Google Knowledge Graph ID is recorded as /g/11byxfy0qd^[10].
• risankizumab's subject has role is recorded as monoclonal antibody^[11].
• risankizumab's RxNorm CUI is recorded as 2166040^[12].
• risankizumab's MedlinePlus drug identifier is recorded as a619035^[13].
• risankizumab's WikiProjectMed ID is recorded as Risankizumab^[14].

Why It Matters

risankizumab ranks in the top 5% of type_of_chemical_entity entities by monthly Wikipedia readership (119 views/month).^[2] risankizumab has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.^[15] risankizumab is known by 8 alternative names across languages and contexts.^[16]